title: Response to Drs Shearer and Ford.
authors.affiliation: Department of Gastroenterology, John Radcliffe Hospital, Oxford, UK.
authors.forename: R W
authors.initials: RW
authors.lastname: Chapman
authors.affiliation: Internal Medicine and Gastroenterology, University of Bologna, Bologna, Italy.
authors.forename: V
authors.initials: V
authors.lastname: Stanghellini
authors.affiliation: Norgine-Medical Affairs, Harefield, UK.
authors.forename: M
authors.initials: M
authors.lastname: Geraint
authors.affiliation: Norgine-Development, Middlesex, UK.
authors.forename: M
authors.initials: M
authors.lastname: Halphen
mesh_terms: D015746:Abdominal Pain / Q000188:drug therapy*; D003248:Constipation / Q000188:drug therapy*; D004573:Electrolytes / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D043183:Irritable Bowel Syndrome / Q000188:drug therapy*; D008297:Male; D011092:Polyethylene Glycols / Q000627:therapeutic use*
chemical_list: D004573:Electrolytes; D011092:Polyethylene Glycols